Capital increase December 2024

Bridge financing of around CHF 6.1 million secures the internationalization step and creates the conditions for institutional funding.

InnoMedica's Board of Directors has decided to carry out a public capital increase to be published in the Swiss Official Gazette of Commerce on 18 November 2024, with a subscription period until 13 December 2024. A maximum of 872,553 new registered shares are to be placed for CHF 7.00 per share, with the subscription rights of existing shareholders being maintained.

Important information about the public offer

Capital increase volumeCHF 6.1 million
Capital increaseOffer of 872,553 new registered shares with a nominal value of CHF 0.10
Issue priceCHF 7.00 per new share
Minimum subscription2,000 new shares at CHF 7.00 (CHF 14,000).
Subscription periodUntil Friday, 13 December 2024
DepositUntil Friday, 13 December 2024
Blocked account at UBS Switzerland AG
In the name of InnoMedica Holding AG, Zug
Capital increase
IBAN: CH22 0023 0230 8867 10D7 L
AllocationDecision of the Board of Directors regarding the subscription rights
ContactInvestor Relations, phone: +41 (0)44 383 88 22, e-mail: ir@innomedica.com
Public offeringPublication in the Swiss Official Gazette of Commerce
Issue prospectus approved by SIX Exchange Regulation AG on 15 November 2024

Investor documents for the 2024 capital increase

The business information update can be ordered using a form.